Details for New Drug Application (NDA): 016996
✉ Email this page to a colleague
NDA 016996 describes HYPERSTAT, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the HYPERSTAT profile page.
The generic ingredient in HYPERSTAT is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
The generic ingredient in HYPERSTAT is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
Medical Subject Heading (MeSH) Categories for 016996
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
